Ambuphylline
Names | |
---|---|
IUPAC name 1,3-dimethyl-7H-purine-2,6-dione : 2-amino-2-methylpropan-1-ol | |
Other names Theophylline aminoisobutanol, bufylline | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChEMBL |
|
ChemSpider |
|
ECHA InfoCard | 100.024.616 |
KEGG |
|
PubChem CID |
|
UNII |
|
CompTox Dashboard (EPA) |
|
InChI
| |
| |
Properties | |
Chemical formula | C11H19N5O3 |
Molar mass | 269.30 g/mol |
Appearance | Crystalline, slightly yellowish white powder |
Melting point | 254 to 256 °C (489 to 493 °F; 527 to 529 K) |
Solubility in water | Freely soluble. |
Pharmacology | |
R03DA10 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references |
Chemical compound
Ambuphylline (or bufylline) is a combination of theophylline and aminoisobutanol used as a bronchodilator.[1] It also acts and may be used as a diuretic.[2]
References
- ^ Smith, J. R.; Jensen, J. (1946). "The effect of theophylline aminoisobutanol in the failing experimental heart". The Journal of Laboratory and Clinical Medicine. 31: 455–457. PMID 21022557.
- ^ Dictionary querymondofacto.com Archived 4 March 2016 at the Wayback Machine
- v
- t
- e
Short-acting β2 agonists | |
---|---|
Long-acting β2 agonists |
|
Ultra-long-acting β2 agonists | |
Other |
muscarinic antagonist
Leukotriene antagonists | |
---|---|
Arachidonate 5-lipoxygenase inhibitors | |
Thromboxane receptor antagonists | |
Non-xanthine PDE4 inhibitors |
- Aclidinium bromide/formoterol
- Beclometasone/formoterol
- Beclometasone/formoterol/glycopyrronium bromide
- Budesonide/formoterol
- Budesonide/glycopyrronium bromide/formoterol
- Fluticasone furoate/umeclidinium bromide/vilanterol
- Fluticasone furoate/vilanterol
- Fluticasone propionate/salmeterol
- Glycopyrronium bromide/formoterol
- Indacaterol/glycopyrronium bromide
- Indacaterol/glycopyrronium bromide/mometasone
- Indacaterol/mometasone
- Ipratropium bromide/salbutamol
- Mometasone/formoterol
- Salbutamol (albuterol)/budesonide
- Theophylline/ephedrine
- Theophylline/ephedrine/hydroxyzine
- Theophylline/ephedrine/phenobarbital
- Umeclidinium bromide/vilanterol
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e